Zobrazeno 1 - 10
of 13
pro vyhledávání: '"R. G. Chulawala"'
Publikováno v:
Indian journal of leprosy. 69(2)
Publikováno v:
Indian journal of leprosy. 67(4)
Autor:
W S, Bhatki, R G, Chulawala
Publikováno v:
Leprosy review. 63(4)
A bacteriological follow-up of 16 lepromatous patients with a high initial Bacteriological Index (BI) showed that in 8 randomly selected patients who received single doses of ICRC Vaccine (C44) at the onset of multidrug therapy, the average reduction
Publikováno v:
Leprosy in India. 48(2)
An analysis of 11,581 leprosy patients registered at the Acworth Leprosy Hospital clinic showed that 494 cases (4.3%) had primary polyneuritic leprosy and 143 (1.2%) localised cutaneous anaesthetic lesions (or non-visible anaesthetic lesions), accoun
Publikováno v:
Leprosy in India. 54(3)
Rifampicin trial in 66 lepromatous cases is reported. Some of these cases were previously treated with Dapsone and some were fresh cases, the main criterion for selection being high BI and MI. The cases were divided into 7 groups depending on the dos
Publikováno v:
Leprosy review. 49(3)
Autor:
R, Ganapati, R G, Chulawala
Publikováno v:
Leprosy in India. 48(1)
Evidence of bacillaemia through examination of heparinised blood smears was obtained in 17 of the 20 cases (85%) of untreated leprosy cases belonging to the spectrum ranging from BT to LL. Among 17 cases whose blood smears were positive for AFB, the
Publikováno v:
Leprosy in India. 48(3)
Publikováno v:
Leprosy in India. 48(4)
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 51(4)
Clinico-pathological features of five cases of lepromatous leprosy exhibiting "reversal" reaction with upgrading of lesions following vaccination with ICRC vaccine have been described. Two patients also developed ENL. Associated with the "reversal" r